Pharma Journalist -

The Microbiome Movement Summit returns in 2025 for its milestone 10th edition, marking a decade of groundbreaking progress and collaborative advancement in microbiome science. This…
Read More...

Septerna, Inc. and Novo Nordisk announced an exclusive global collaboration and license agreement to discover, develop and commercialise oral small molecule medicines for obesity, type…
Read More...

BioCryst Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for the use of oral, once-daily ORLADEYO …
Read More...

AbbVie announced that EMRELIS (telisotuzumab vedotin-tllv) has been granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with…
Read More...

Stylus Medicine, Inc. (“Stylus”), a biotechnology company dedicated to developing transformative in vivo genetic medicines, emerges from stealth with $85 million in financing. Stylus’…
Read More...

GSK plc and Boston Pharmaceuticals announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is…
Read More...

Tempus AI, Inc. announced a new strategic collaboration to advance Boehringer Ingelheim’s growing cancer pipeline. The new, multi-year collaboration builds on foundational work the two…
Read More...

AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA therapeutics, announced a collaboration and license option agreement to…
Read More...

Recipharm and ProductLife Group (PLG) announced a strategic collaboration aimed at supporting (bio)pharmaceutical companies in accelerating time to clinical trials and market approval…
Read More...

LONDON, UK – 24–25 June 2025 Projected to reach $1,139.4 billion by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution? From complex…
Read More...